Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • LacquerHead
    Member
    • Nov 2015
    • 31

    Advice on combining PE125 and PE75 data

    Hi all,

    Have two experiments, one run on HiSeq PE125 and the other on NextSeq PE75, same V4 chemistry for both. I have thus far chopped 49bp off the PE125 output to get the same 76bp data as from NextSeq to combine replicates. It seems to be ok in terms of downstream peak calling etc, wondering everyones thoughts on whether this is kosher and if so is there a best approach? Thanks!
  • mrandel
    Junior Member
    • Sep 2013
    • 3

    #2
    I have successfully combined reads from multiple sequencing runs on different Nextera instruments with no problems, as long as the quality scores are reported in the same way.

    Comment

    • LacquerHead
      Member
      • Nov 2015
      • 31

      #3
      I guess my central question is whether its ok to combine mapped reads as replicates when they come from PE125 and PE75? In terms of coverage etc etc? Or is my modification of the 125 to 75 appropriate?
      Thanks.

      Originally posted by mrandel View Post
      I have successfully combined reads from multiple sequencing runs on different Nextera instruments with no problems, as long as the quality scores are reported in the same way.

      Comment

      • Dario1984
        Senior Member
        • Jun 2011
        • 166

        #4
        Trimming is the best way to make the datasets comparable.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...